{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:39:13Z","timestamp":1789767553847,"version":"4.0.1"},"reference-count":45,"publisher":"Impact Journals, LLC","issue":"38","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,8]]},"DOI":"10.18632\/oncotarget.19041","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T23:49:42Z","timestamp":1499384982000},"page":"64407-64416","source":"Crossref","is-referenced-by-count":10,"title":["Diagnostic value of D2-40 immunostaining for malignant mesothelioma: a meta-analysis"],"prefix":"10.18632","volume":"8","author":[{"given":"Chao","family":"He","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, West China Hospital of Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University and Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University and Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchun","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University and Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,7,6]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"24A","DOI":"10.2471\/BLT.11.086678","article-title":"Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008","volume":"89","author":"Sorahan","year":"2011","journal-title":"Bull World Health Organ"},{"key":"2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Lake","year":"2005","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/CLEP.S105396","article-title":"Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival","volume":"8","author":"Gadgeel","year":"2016","journal-title":"Clin Epidemiol"},{"key":"4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Fraire","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"5","doi-asserted-by":"publisher","first-page":"59314","DOI":"10.18632\/oncotarget.10653","article-title":"Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma","volume":"7","author":"Pastorino","year":"2016","journal-title":"Oncotarget"},{"key":"6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/oem.2005.023200","article-title":"The French National Mesothelioma Surveillance Program","volume":"63","author":"Astoul","year":"2006","journal-title":"Occup Environ Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jtho.2016.04.028","article-title":"Consensus Report of the 2015 Weinman International Conference on Mesothelioma","volume":"11","author":"Gavett","year":"2016","journal-title":"J Thorac Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jtho.2016.12.006","article-title":"Improving the Accuracy of Mesothelioma Diagnosis in China","volume":"12","author":"Wang","year":"2016","journal-title":"J Thorac Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/sj.bjc.6690393","article-title":"Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours","volume":"80","author":"Baumal","year":"1999","journal-title":"Br J Cancer"},{"key":"10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/modpathol.3880543","article-title":"Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas","volume":"15","author":"Marks","year":"2002","journal-title":"Mod Pathol"},{"key":"11","first-page":"95","article-title":"Accuracy of immunohistochemistry in evaluation of malignant pleural and peritoneal effusions","volume":"62","author":"Irvanlou","year":"2011","journal-title":"Pol J Pathol"},{"key":"12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/dc.20986","article-title":"Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks","volume":"37","author":"Choi","year":"2009","journal-title":"Diagn Cytopathol"},{"key":"13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5858\/2008-132-23-CMVBHU","article-title":"Cytologic malignancy versus benignancy: how useful are the \u201cnewer\u201d markers in body fluid cytology?","volume":"132","author":"Coffey","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"14","first-page":"817","article-title":"The role of immunohistochemistry in the diagnosis of neoplastic pleural effusions","volume":"53","author":"Georgescu","year":"2012","journal-title":"Rom J Morphol Embryol"},{"key":"15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-6-9","article-title":"Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies","volume":"6","author":"Kleijnen","year":"2006","journal-title":"BMC Med Res Methodol"},{"key":"16","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed","volume":"58","author":"Irwig","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/01.pas.0000208280.29291.34","article-title":"D2-40 is not a specific marker for cells of mesothelial origin in serous effusions","volume":"30","author":"Davidson","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/dc.20556","article-title":"The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement","volume":"34","author":"Silverman","year":"2006","journal-title":"Diagn Cytopathol"},{"key":"19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/dc.20633","article-title":"Diagnostic utility of D2-40 and podoplanin in effusion cell blocks","volume":"35","author":"Mandavilli","year":"2007","journal-title":"Diagn Cytopathol"},{"key":"20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1159\/000339586","article-title":"The diagnostic utility of D2-40, calretinin, CK5\/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology","volume":"56","author":"Tabatabai","year":"2012","journal-title":"Acta Cytol"},{"key":"21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.humpath.2005.01.019","article-title":"D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma","volume":"36","author":"Ordonez","year":"2005","journal-title":"Hum Pathol"},{"key":"22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/modpathol.3800259","article-title":"Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma","volume":"18","author":"Zhang","year":"2005","journal-title":"Mod Pathol"},{"key":"23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000093091","article-title":"D2-40: a reliable marker in the diagnosis of pleural mesothelioma","volume":"73","author":"Muller","year":"2006","journal-title":"Pathobiology"},{"key":"24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/modpathol.3800471","article-title":"The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study","volume":"19","author":"Ordonez","year":"2006","journal-title":"Mod Pathol"},{"key":"25","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/PAS.0b013e318033e7a8","article-title":"h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary","volume":"31","author":"Messerini","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"26","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/cncr.22477","article-title":"Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma","volume":"109","author":"Okada","year":"2007","journal-title":"Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/PAS.0b013e31814faacf","article-title":"Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin","volume":"32","author":"Mills","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2559.2009.03322.x","article-title":"Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma","volume":"55","author":"Inai","year":"2009","journal-title":"Histopathology"},{"key":"29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.prp.2009.06.001","article-title":"Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations?","volume":"205","author":"Bakir","year":"2009","journal-title":"Pathol Res Pract"},{"key":"30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2559.2009.03298.x","article-title":"Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma","volume":"54","author":"Inai","year":"2009","journal-title":"Histopathology"},{"key":"31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/PAI.0b013e3181da8387","article-title":"Value of D2-40 in the differential diagnosis of pleural neoplasms with emphasis on its positivity in solitary fibrous tumor","volume":"18","author":"Xu","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/PAT.0b013e32834642da","article-title":"Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma","volume":"43","author":"Klebe","year":"2011","journal-title":"Pathology"},{"key":"33","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1700\/1660.18182","article-title":"Expression of thrombomodulin, calretinin, cytokeratin 5\/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma","volume":"100","author":"Messerini","year":"2014","journal-title":"Tumori"},{"key":"34","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/jclinpath-2015-203211","article-title":"Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses","volume":"69","author":"Hiroshima","year":"2016","journal-title":"J Clin Pathol"},{"key":"35","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/modpathol.2016.181","article-title":"MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma","volume":"30","author":"Takeshima","year":"2017","journal-title":"Mod Pathol"},{"key":"36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/his.13073","article-title":"Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma","volume":"70","author":"Takeshima","year":"2017","journal-title":"Histopathology"},{"key":"37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.chest.2016.12.004","article-title":"Malignant mesothelioma biomarkers - from discovery to use in clinical practise for diagnosis, monitoring, screening and treatment","volume":"152","author":"Robinson","year":"2016","journal-title":"Chest"},{"key":"38","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1309\/QLV6-HH0H-UCTF-WEF6","article-title":"WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids","volume":"117","author":"Pinkus","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"39","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart","volume":"10","author":"Nicholson","year":"2015","journal-title":"J Thorac Oncol"},{"key":"40","first-page":"14","article-title":"The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura","volume":"1","author":"Corson","year":"2011","journal-title":"Am J Cancer Res"},{"key":"41","doi-asserted-by":"publisher","first-page":"84851","DOI":"10.18632\/oncotarget.12707","article-title":"Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"42","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/bjc.2017.20","article-title":"Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma","volume":"116","author":"Brims","year":"2017","journal-title":"Br J Cancer"},{"key":"43","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.5858\/2005-129-1407-IDOEMA","article-title":"Immunohistochemical diagnosis of epithelioid mesothelioma: an update","volume":"129","author":"Ordonez","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification","volume":"11","author":"Travis","year":"2016","journal-title":"J Thorac Oncol"},{"key":"45","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.18632\/oncotarget.13174","article-title":"Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis","volume":"8","author":"Fontanini","year":"2017","journal-title":"Oncotarget"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T10:06:53Z","timestamp":1692871613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,6]]},"references-count":45,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2017,9,8]]}},"alternative-id":["19041","28969080"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.19041","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,6]]}}}